MEDICAL ASIAMEDICAL PLATFORM
한국어English中文日本語РусскийالعربيةEspañolМонголBahasa Indonesia

Information compiled by Medical Asia from public sources.

Retina/vitreous disease

Retina & Vitreous Disorders

PART I

Information items

01Institutional capabilities and essential infrastructure

Retina and vitreous specialists, mydriasis/wide-field fundus photography, OCT/OCTA, fluorescein/indocyanine green angiography, ocular ultrasound/electrophysiology, laser and aseptic intravitreal injection facilities are required. The operating room should be equipped with a wide-angle viewing system, small-gauge vitrectomy instruments, guidance lasers, perfluorocarbon, gas/silicone oil, scleral buckling materials, and anesthesia/emergency response, to handle simultaneous cataract surgery and reoperations.

02System capabilities and collaborative-care structure

Classify photopsia, floaters, and curtain-type visual disturbances with same-day dilation tests, and connect macula-sparing retinal detachments to an emergency surgery pathway. Standardize anti-VEGF treatment-extension based on OCT or administration as needed with guidance for endophthalmitis management. Collaborate with endocrinology/kidney, neurology/cardiology/radiology, pediatrics/NICU, infection/rheumatology/genetics/low vision rehabilitation, and educate on postoperative positioning, flight, nitrous oxide contraindications, and alternative follow-up measures.

03Recognition unit

Programs recognized include university hospital programs with dedicated retina and vitreous specialists and independent clinics, performing wide-angle imaging/OCT, angiography, laser treatments, injections, vitrectomy, emergency retinal detachment surgeries, reoperations, collaboration for systemic diseases, and long-term follow-up quality management.

04Evidence and verification criteria

Priority is given to AAO clinical information, preferred treatment guidelines, and official hospital clinics, equipment, medical staff, and surgical data. Confirm symptom–pupil dilation test time, retinal detachment surgery wait time, single reattachment, final attachment/vision, reoperation, endophthalmitis, retinal tear, injection interval, follow-up dropout, diabetic retinopathy screening rate, and patient-reported visual function.

05Currency status

Source currency has been confirmed; official verification is in progress.

06SEO and AI search architecture

Emergency retinal detachment surgery, vitrectomy, diabetic retinopathy treatments, macular degeneration injections, macular hole surgery, retinal vascular occlusions, uveitis, retinopathy of prematurity, retina specialist Korea, vitrectomy Korea.

PART II

Detailed information item

01Definition of specialist medical care and domestic and international clinical statistics (Definition & Epidemiological Context)

The retina converts light into neural signals, and the vitreous is the transparent tissue filling the inside of the eye. If the retina detaches or macular, vascular, or diabetic changes occur, central and peripheral vision can be permanently damaged. Retinal tears/detachments are time-sensitive conditions requiring laser or surgery, and macular degeneration/diabetic macular edema needs long-term monitoring of anatomical and functional responses through OCT and repeated anti-VEGF treatments.

02Patient problem and clinical entry point (Patient Problem Layer)

Sudden flashes, increase in floaters, curtain blocking vision, rapid vision loss or distortion, blurry vision in diabetics, vision loss accompanied by pain or redness are entry points. Prioritize ruling out new holes, retinal detachment, vitreous hemorrhage, and endophthalmitis and transfer promptly to a center capable of surgery if surgery is needed before macular involvement.

03Precision Diagnostics and Functional Evaluation System (Diagnostics & Functional Evaluation)

Combine best-corrected visual acuity, intraocular pressure, slit-lamp, and dilated fundus examination with wide-angle fundus photography, macula/optic nerve OCT/OCTA, fluorescein/ICG angiography, and ocular ultrasound. If necessary, perform ERG/EOG, visual field, color vision, blood tests/infection, autoimmune, and genetic testing, and structure information on the location of retinal tears, extent of detachment, macular status, stage of proliferative membranes, and risk to the other eye.

04Treatment Methods and Timeline-based Care Pathway

Step 1: Same-day risk classification · confirmation → using pupil dilation examination · OCT/wide-angle imaging · ultrasound to distinguish macular hole · detachment · hemorrhage · inflammation.

Phase 2: Plan laser, injection, or emergency surgery → determine indications for perforation laser, anti-VEGF/steroid, scleral buckling, and vitrectomy.

Stage 3: Microsurgery and acute care → perform vitrectomy, membrane removal, guide laser, gas/silicone filling, and infection prevention.

Stage 4: Vision recovery and recurrence management → follow OCT-based injection intervals, retinal reattachment, intraocular pressure, cataracts, opposite eye, systemic disease, and low vision rehabilitation.

05Institutions performing specialized medical care for retina and vitreous diseases and multidisciplinary directories

Seoul

Region not confirmed

This page is public information based on official sources and administrator verification, and does not constitute medical advice or guarantee the excellence of a specific institution or specialist.